Liraglutide recalls

The FDA has published 3 recalls involving Liraglutide since 2021. The latest was reported on 27 May 2026. Most were for temperature abuse. Novo Nordisk has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2021

Last 12 months1reported

Class I00% of total

Ongoing1latest 27 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 1 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why liraglutide is recalled

Temperature Abuse267%
Particulate Matter133%

Companies

Novo Nordisk267%
Lupin Pharmaceuticals133%

Brands

By year

2026133%
2021267%

Ongoing liraglutide recalls

1 active

Reported	Class	Recall	Company	Reason	Where
27 May 2026Drug	CLASS II	Liraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutide	Lupin Pharmaceuticals	Particulate Matter	Nationwide

All liraglutide recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
27 May 2026Drug	CLASS II	Liraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutide	Lupin Pharmaceuticals	Particulate Matter	Nationwide
21 Apr 2021Drug	CLASS II	ViCTOZA (liraglutide) injection, 18 mg/ (6 mg/mL), contains recalledVictoza	Novo Nordisk	Temperature Abuse	Nationwide
21 Apr 2021Drug	CLASS II	Saxenda (liraglutide) Injection, 18 mg/ (6 mg/mL) recalledSaxenda	Novo Nordisk	Temperature Abuse	Nationwide

Should you stop taking Liraglutide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.